{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:26:08Z","timestamp":1786991168461,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.isci.2022.105019","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T20:07:46Z","timestamp":1661630866000},"page":"105019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1143-5483","authenticated-orcid":false,"given":"Courtney M.","family":"Mazur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian D.","family":"Castro Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicha","family":"Tokavanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadatoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Bouxsein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-8147","authenticated-orcid":false,"given":"Marc N.","family":"Wein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2022.105019_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bonr.2018.09.004","article-title":"Glucocorticoids cause mandibular bone fragility and suppress osteocyte perilacunar-canalicular remodeling","volume":"9","author":"Alemi","year":"2018","journal-title":"Bone Rep."},{"key":"10.1016\/j.isci.2022.105019_bib2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro\u2013computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.isci.2022.105019_bib3","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMcp1800214","article-title":"Glucocorticoid-induced osteoporosis","volume":"379","author":"Buckley","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2022.105019_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1074-7613(00)80398-2","article-title":"A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR\/CD3-activated cell death","volume":"7","author":"D\u2019Adamio","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2022.105019_bib5","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.celrep.2017.10.115","article-title":"Osteocyte intrinsic TGF\u03b2 signaling regulates bone quality through perilacunar\/canalicular remodeling","volume":"21","author":"Dole","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2022.105019_bib6","doi-asserted-by":"crossref","first-page":"36513","DOI":"10.1038\/srep36513","article-title":"Strain dependent differences in glucocorticoid-induced bone loss between C57BL\/6J and CD-1 mice","volume":"6","author":"Ersek","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2022.105019_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/srep44618","article-title":"Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis","volume":"7","author":"Fowler","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2022.105019_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bone.2018.06.001","article-title":"Genome-wide association study of extreme high bone mass: Contribution of common genetic variation to extreme BMD phenotypes and potential novel BMD-associated genes","volume":"114","author":"Gregson","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.isci.2022.105019_bib9","first-page":"1","article-title":"Function of cGMP-dependent Protein Kinases as Revealed by Gene Deletion","volume":"86","author":"Hofmann","year":"2006"},{"key":"10.1016\/j.isci.2022.105019_bib10","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1096\/fj.11-182519","article-title":"Glucocorticoid dose determines osteocyte cell fate","volume":"25","author":"Jia","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2022.105019_bib11","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1172\/JCI94912","article-title":"Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance","volume":"127","author":"Kanai","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2022.105019_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.isci.2022.105019_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12603-015-0652-3","article-title":"Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: a systematic review","volume":"21","author":"Khow","year":"2017","journal-title":"J.\u00a0Nutr. Health Aging"},{"key":"10.1016\/j.isci.2022.105019_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1359\/JBMR.051103","article-title":"Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice","volume":"21","author":"Lane","year":"2006","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.isci.2022.105019_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41413-019-0070-y","article-title":"Osteocyte dysfunction promotes osteoarthritis through MMP13-dependent suppression of subchondral bone homeostasis","volume":"7","author":"Mazur","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.isci.2022.105019_bib16","doi-asserted-by":"crossref","first-page":"e71931","DOI":"10.7554\/eLife.71931","article-title":"C-type natriuretic peptide facilitates autonomic Ca(2+) entry in growth plate chondrocytes for stimulating bone growth","volume":"11","author":"Miyazaki","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.isci.2022.105019_bib17","doi-asserted-by":"crossref","first-page":"36454","DOI":"10.1074\/jbc.M708596200","article-title":"Osteocrin is a specific ligand of the natriuretic peptide clearance receptor that modulates bone growth","volume":"282","author":"Moffatt","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2022.105019_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/JVI.79.1.214-224.2005","article-title":"Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice","volume":"79","author":"Nakai","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2022.105019_bib19","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O\u2019Brien","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2022.105019_bib20","doi-asserted-by":"crossref","first-page":"E587","DOI":"10.1152\/ajpendo.00219.2016","article-title":"Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice","volume":"311","author":"Piemontese","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2022.105019_bib21","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2022.105019_bib22","doi-asserted-by":"crossref","first-page":"24120","DOI":"10.1074\/jbc.M611435200","article-title":"Glucocorticoids induce osteocyte apoptosis by blocking Focal adhesion kinase-mediated survival","volume":"282","author":"Plotkin","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2022.105019_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41413-020-0099-y","article-title":"Molecular mechanosensors in osteocytes","volume":"8","author":"Qin","year":"2020","journal-title":"Bone Res."},{"key":"10.1016\/j.isci.2022.105019_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2022.105019_bib25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2022.105019_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115320","article-title":"Male\u00a0mice with elevated C-type natriuretic peptide-dependent guanylyl cyclase-B activity have increased osteoblasts, bone mass and bone strength","volume":"135","author":"Robinson","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.isci.2022.105019_bib27","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.40874","article-title":"Denosumab versus risedronate in glucocorticoid-induced osteoporosis: final results of a twenty-four\u2013month randomized, double-blind, double-dummy trial","volume":"71","author":"Saag","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.isci.2022.105019_bib28","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.isci.2022.105019_bib29","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1038\/s41467-020-17099-3","article-title":"A FAK\/HDAC5 signaling axis controls osteocyte mechanotransduction","volume":"11","author":"Sato","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105019_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJMoa1813446","article-title":"C-type natriuretic peptide analogue therapy in Children with achondroplasia","volume":"381","author":"Savarirayan","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2022.105019_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jot.2018.07.001","article-title":"Strain-specific differences in the development of bone loss and incidence of osteonecrosis following glucocorticoid treatment in two different mouse strains","volume":"16","author":"Shidara","year":"2019","journal-title":"J.\u00a0Orthop. Translat."},{"key":"10.1016\/j.isci.2022.105019_bib32","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1074\/jbc.M114.628313","article-title":"The wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in\u00a0vitro","volume":"290","author":"Spatz","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2022.105019_bib33","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3899\/jrheum.081207","article-title":"Once-weekly oral alendronate 70\u00a0mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial","volume":"36","author":"Stoch","year":"2009","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.isci.2022.105019_bib34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1530\/EC-19-0104","article-title":"Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans","volume":"8","author":"Thiele","year":"2019","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.isci.2022.105019_bib35","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/jbmr.1688","article-title":"Selective glucocorticoid receptor modulation maintains bone mineral density in mice","volume":"27","author":"Thiele","year":"2012","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.isci.2022.105019_bib36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/ajpendo.00646.2007","article-title":"The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene","volume":"295","author":"Waddell","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2022.105019_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","article-title":"Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy","volume":"67","author":"Wallach","year":"2000","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.isci.2022.105019_bib38","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1038\/s41467-021-26571-7","article-title":"Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105019_bib39","doi-asserted-by":"crossref","first-page":"15941","DOI":"10.1073\/pnas.0707246104","article-title":"A model for the role of integrins in flow induced mechanotransduction in osteocytes","volume":"104","author":"Wang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2022.105019_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109380","article-title":"Mechanical load regulates bone growth via periosteal Osteocrin","volume":"36","author":"Watanabe-Takano","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2022.105019_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13176","article-title":"SIKs control osteocyte responses to parathyroid hormone","volume":"7","author":"Wein","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105019_bib42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2022.105019_bib43","first-page":"2907","article-title":"Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip","volume":"85","author":"Weinstein","year":"2000","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2022.105019_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/acsabm.8b00246","article-title":"Compliant substratum changes osteocyte functions: the role of ITGB3\/FAK\/\u03b2-Catenin signaling matters","volume":"1","author":"Xie","year":"2018","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.isci.2022.105019_bib45","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/art.23454","article-title":"Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.isci.2022.105019_bib46","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004222012913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004222012913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:03:43Z","timestamp":1762880623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004222012913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2589004222012913"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2022.105019","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2022.105019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"105019"}}